[1]
E. Alkhalil, B. Jarad, T. Saleh, W. Aldarwish, and D. Joujeh, “BioNTech/Pfizer (BNT162b2) COVID-19 mRNA vaccine: manufacturing, immunogenicity, efficacy and safety”, Prosp. Pharm. Sc., vol. 23, no. 1, pp. 31–46, Feb. 2025.